Share Name Share Symbol Market Type Share ISIN Share Description
Tekcapital Plc LSE:TEK London Ordinary Share GB00BKXGY798 ORD �0.004
  Price Change % Change Share Price Shares Traded Last Trade
  -0.25 -1.69% 14.50 1,231,402 14:39:37
Bid Price Offer Price High Price Low Price Open Price
14.00 15.00 14.75 13.75 14.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 5.36 3.57 8.08 2.0 19
Last Trade Time Trade Type Trade Size Trade Price Currency
16:23:40 O 4,585 14.70 GBX

Tekcapital (TEK) Latest News (1)

More Tekcapital News
Tekcapital Investors    Tekcapital Takeover Rumours

Tekcapital (TEK) Discussions and Chat

Tekcapital (TEK) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Tekcapital trades in real-time

Tekcapital (TEK) Top Chat Posts

Tekcapital Daily Update: Tekcapital Plc is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker TEK. The last closing price for Tekcapital was 14.75p.
Tekcapital Plc has a 4 week average price of 10.25p and a 12 week average price of 10p.
The 1 year high share price is 21.50p while the 1 year low share price is currently 8.25p.
There are currently 130,828,042 shares in issue and the average daily traded volume is 2,694,210 shares. The market capitalisation of Tekcapital Plc is £18,970,066.09.
buywell2: Short term buywell has already posted a TEK chart which shows 20p as a first resistance level Assuming no RNS News on any other company between now and the Belluscura AIM Floatation , other than Belluscura of course, to get through that level , Clifford explain to shareholders : 1) What will be the special dividend eg will it be 50% of TEK holding in Belluscura? 2) If so what will the other cash be used for eg will TEK Snack Foods Ltd take the place of Belluscura to become the new number 4 ( Crackle-Bake trademarked ) reduces Fat by 60% with patented coating --- one can see the WHO doing benchmarks on Sugar and Fat next on their Obesity drive. htTps:// 3) Or if not number 2) what is the replacement to be ? TEK have several other interesting patents 4) Or has there been a development in the Guident shock absorber patent that opens another NEW company door to further perhaps co-develop the unique patent if it has shown promise under testing --- there is a big market for that product alone. 5) Will say a 50% special dividend become the Norm --- it would not be a bad idea imo and give some degree of forward investment planning to TEK shareholders. One thing is for sure: The TEK CEO is IMO a very happy guy at the moment --- whilst there are some olde stale TEK Bulls still mooing , the future of TEK has IMO never looked better. Guident looks set to become the star performer as more and more states allow driverless cars on to their roads. Medium term With a positive RNS on any other company 30p resistance could next then be challenged This move to 30p could be quicker now TEK can't determine when another company wants to sign a deal . The BIG companies are in the driving seat so newsflow is under their control, buywell has a gut feeling the next news that has major share price movement potential could well be salt related, as you may have guessed. 45p next resistance for those that stay the course and like what the CEO outlines imo dyor
buywell2: This is taken from the recent TEK results 30th April 2021 last week Group ------------------------------ Belluscura Proportion of ordinary shares held -- 17.82% 1 Dec 2019 -------------------------- US$ 1,804,121 Additions --------------------------- US$ 224,163 30 Nov 2020 ------------------------- US$ 2,081,027 ( bit of fx change) Now Tekcapital own circa 23% of Belluscura having used 1.25 Million GBP to buy them or in US$ 1,750,000 So a total outlay (not taking fx changes into account) of circa US$ 3,831,027 On a successful AIM Float later this month that stake should be worth around 8M pounds or US$ 11,193,000 So the NAV of 35 cents a share in the results is out of date Based upon the AIM Floatation another US$ 7,361,973 needs to be added to the total of US$ 30,491,657 An uplift of 24.144% to the old NAV from 35cents to 43.5cents Which equates to 31p a share At todays close TEK still trades at more than a 50% discount to NAV dyor
buywell2: Before the placing there were circa 92M shares in issue Following the issue of the 38,000,000 New Ordinary Shares the total number of ordinary shares in issue with voting rights in the Company will be 130,828,042 . So another 41% of shares sold at 10p --- primarily in my view to acquire the warrants in Belluscura which were about to lapse TEK said ----- £1.25m will be used to exercise warrants and options held in Belluscura plc, which will increase Tekcapital's equity stake by approximately 70% to approximately 17.1m shares and the remainder will primarily be committed to Tekcapital's portfolio of companies and to provide additional working capital for the Company. There has been no RNS yet to explain where around 40% of TEK shares landed But certainly there has been many millions of shares sold since the raising by some parties buywell seems to remember reading about certain Funds NOT being required to RNS if they did not which to , possibly foreign or with a 10% caveat, perhaps someone can clarify that one. From that chart buywell would infer circa VOL of 40M shares traded ie 20M bought/sold Probably slightly more than 20M bought as the share price has played with 12p a couple of times, the next positive RNS , particularly if it is about Belluscura , should put the remainder of such sales to bed imo dyor
buywell2: The Chart of TEK IMO is looking decent at this present time free stock charts from Whilst the 3.8 Million recently raised at 10p hurt it , it is looking like good news flow and what TEK intend to do with the cash have for now got the chart back into a positive mode 2021 is being said to be a transformation year for the company by its boss Belluscura has been mentioned very recently as possibly being its first chance to realize cash from its Belluscura holding via an IPO , which imo would be considerably enhanced by the 2 patents referred to in buywells last post being granted. Belluscura considered joining AIM back in 2017 ---- there is an RNS to that effect So one would imagine the prospectus for such an AIM flotation is 99% ready and there remains just a few spaces in it to fill in . ie no waiting time imo other than for the 2 patents mentioned The case and need for home and hospital/Care Homes oxygen therapy for a variety of illnesses was a given back in 2017. But since then Obesity levels have continued to rise and with Covid-19 lockdowns have turbo charged the problem for all age groups --- plus Covid-19 in 2020 has placed and is in the process of placing --- HUGE demands for oxygen in ICU's and OR's , wards and Care Homes as the elderly and the obese have been worst affected by this pandemic . Unfortunately new variants like P1 in Brazil and South America are now also affecting the young as well and plus the South African variant also spreading worldwide as is P1 --- the pandemic shows no sign of going away BUT it is leaving a trail of devastation in its wake in the form of long COVID organ damaged survivors. A large proportion of those will have scarred and damaged lungs together with breathing difficulties . Some of those will be permanent and many will need home oxygen therapy also. This is a problem, the severity of which, Health Services and Authorities are just starting to become aware of --- future implications and costs can only be descibed as imo highly complex , very costly and very concerning . Belluscura with its newly 510(k) approved oxygen concentrator that has a number of very unique advantages over similar existing products could , it has been said , float at around 50M This would make the TEK 30% stake worth 15M It has also been said that a special dividend of circa 50% of such monies would be paid to TEK shareholders --- the TEK boss has ( from memory) around 7.5 million shares or circa just under 6% of TEK and another recently joined Institution just over 6% , plus Nigel Wray has around 5% --- so this could well happen This would still leave 7.5M cash to add to what cash was left from the circa 2.5M left today ( 1.25M used to acquire more Belluscura shares from 10p placing by TEK) and existing cash. Based upon the current Market Cap of Tekcapital today of 14.72M one can imo only deduce that if Belluscura does float and hit circa 50M valuation expectation --- then TEK shares would be worth imo conservatively 23p The Market at present has not imo factored in the likelihood of Belluscura being floated this year. Whilst most times Mr Market gets things right Very occasionally however Mr Market does make a boo boo --- is this one of those times ? If it has perhaps the TEK chart could hit around 23p in this sort of timeframe ( 2 patents grated july time ) free stock charts from However a prior 'Notice of Allowance ' of a patent grant could come a month or so prior to that date : Issuance of the Notice of Allowance According to Section 13(b)(2) of the Trademark Act, the Notice of Allowance is provided if the application is not opposed. The notice is an intent-to-use application informing the inventor that the patent will be issued about eight weeks from the marked publishing date. always dyor
danmart2: TEK price looks a bit cheap under 16p
buywell2: --------------------- Guident and Bestmile -------------------------- Remember that Guident is getting established in the state of Florida BUT there are several other states that seem likely to also follow the Florida strategy for Control Centre adoption re no actual human driver requirement in an autonomous vehicle. buywell surmises that in states that do not adopt such Control Centre strategies , the first time chaos followed by gridlock occurs --- things could rapidly change to a Control Centre methodology. Some developments: 7th Sept 2020 Tekcapital’s Guident enters strategic alliance with Bestmile htTps:// The alliance will see Guident provide its patented, advanced teleoperation to Bestmile for autonomous and human-driven vehicles to enhance customer safety and security, incorporating a reliable, low latency connection to any advanced mobile network solution. buywell note: Low latency describes a computer network that is optimized to process a very high volume of data messages with minimal delay (latency). These networks are designed to support operations that require near real-time access to rapidly changing data. The recent deal with Cirrus Core Networks enhances this 'almost real time' connection buywell was interested to read that driverless autonomous vehicles had already been used by Mayo Clinic in Florida ( Probably the Number One Cancer Treatment clinic in America ), to deliver Covid-19 testing materials along with Bestmile involvement April 2020 Autonomous vehicles helping transport COVID-19 tests at Florida Mayo Clinic Jacksonville Transportation Authority and its partners created, tested, and deployed the AV routes hTtps:// Jacksonville Transportation Authority (JTA), Beep, NAVYA, and Bestmile partnered to create, test, and deploy the routes for the autonomous vehicles at Mayo Clinic in Florida to address the fluid developments of the COVID-19 pandemic. The Jacksonville Transportation Authority has actively tested autonomous vehicle technology since 2017 to prepare for a conversion and expansion of its Jacksonville Skyway automated people-mover in downtown Jacksonville into a network powered by autonomous vehicles. Self-driving shuttles, COVID-19 and the Mayo Clinic Autonomous vehicles experiments have paid off in Jacksonville, FL, for both the city and the Mayo Clinic campus there. About two weeks ago, driverless shuttles began transporting medical supplies and COVID-19 tests from drive-through testing locations to labs within the hospital grounds. Four autonomous vehicles run the route in full autonomous mode without attendants or other people onboard. A human driving a car follows the autonomous shuttle, and operators monitor it from a command centre. -------------------------------------------------------------------------------------------------- Guident has stated it intends to use its technology to monitor/control land based drones for the likes of food deliveries and medical deliveries for example ---- both huge markets in their own right Everyone has to eat/drink and Americans are taking more prescription medicines: there were 5.8 billion prescriptions dispensed in the United States in 2018, up 2.7% from 2017 More than 1 in every 2 Americans are taking a prescription drug Nearly 80% of elderly Americans likewise hTtps:// This last stage in the delivery chain has become known as the last mile The growth in home delivery is focusing attention on what logistics experts call "the last mile." That does not mean literally a mile; it means the last piece of this supply chain And the reason it's interesting is it's the most expensive mile of the whole thing. Estimates of more than 50% of the supply chain cost is from that last mile. It's expensive because it's labor-intensive as at present there is a driver who takes every package up to the front door. Estimates run that free shipping will cost Amazon more than a billion dollars in a quarter . Which explains why shippers are looking at some radical new technologies to cut the cost of the last mile. Hence land based drones are now being deployed buywell thinks this last mile is by far the most lucrative and worthy of attention Tekcapital’s Guident files new patent for remote monitoring technology hTtps:// This new patent teaches methods and procedures for improving the real-time, intelligent monitoring and control of AV's and land-based delivery drones The application, which aims to enhance the safety of autonomous vehicles, robots, or drones, is directed to a smart remote monitoring device and remote monitoring control centre that monitors the incident risk level and remotely takes control of the device. Plus a further partnership with Cirrus Core Networks hTtps:// Guident provides patented artificial intelligent solutions for autonomous vehicles and ground-based delivery drones including valet systems, concierge services, remote monitoring and control and connected vehicle data sharing for active safety. Additionally, Guident's teleoperation system is designed to integrate within smart cities to improve the safety and performance of transportation in the smart city environment.
oldtimer169: The uncertainty over a Belluscura IPO-Its timing and valuation plus the placing overhang is clearly holding back the share price It is noteworthy that recent holding notifications indicate some holders above 3% did not participate in the placing.TEK's decision to take up their full entitlements in Belluscura suggest an IPO will take place on terms favourable to TEK shareholders.Time will tell if their optimism is justified.The market seems unconvinced ATM.DYOR
oldtimer169: Ptolemy, An interesting analogy.However,I would add a further dimension that one of the daughters marries someone who wins the lottery and buys you a carribean island as a 'thankyou'.In the case of TEK the 'jackpot' takes the form of a major tech company that loves one or more of your patents and either buys the IP or more likely takes you out at a massive premium to the share price.That's the risk/reward here and on a positive note,the risk is spread across several possibilities.DYOR
someuwin: SP Angel: Tekcapital PLC (TEK.L*): 510(k) Clearance Granted for Belluscura's X-PLO2R POC Share price: 14.5p; Market capitalisation: £13.5m Tania Maciver, Special Situations Analyst * The US FDA has granted 510(k) clearance and marketing authorisation for the use of Belluscura's X-PLO2R portable oxygen concentrator (POC). * This is Belluscura’s first newly developed product to be granted clearance by the FDA, and given the timing, priority clearance appears to have been granted. * The X-PLO2R is expected to be launched in US market later this year. Notably, Belluscura is also considering the viability of an IPO on the AIM market of the LSE following this announcement. * Additional detail can be found in the full note here. TEK currently owns 17.8% of Belluscura or 10.5m shares: As a long-term supporter of Belluscura, TEK has maintained a substantial shareholding for several years, and has a number of warrants and options to acquire more shares in Belluscura. If all options are exercised, TEK could hold approximately 17.1m shares of Belluscura. With the number of portfolio company developments achieved so far this year, we believe TEK stock remains undervalued. We continue to expect a re-rating of the shares once some key near-term milestones are achieved.
faz: I expect a cash raise so Tek can acquire its options- the higher the share price the better when that happens. They may place this with institutions to secure a quick deal. I think £16m market cap is laughable. Once first orders come into Bell we'll see this move. I do not expect Tek to participate in any cash raise associated with a Bell IPO; it would skew its investment strategy too much to one company. But imho we will be looking at a much higher share price in three months.
Tekcapital share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210513 17:03:24